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ABSTRACT
Cytoplasmic polyadenylation regulates mRNA stability and translation and is required for early development and synaptic
plasticity. The GLD-2 poly(A) polymerase catalyzes cytoplasmic polyadenylation in the germline of metazoa. Among vertebrates,
the enzyme is encoded by two isoforms of mRNA that differ only in the length of their 39-UTRs. Here we focus on regulation of
vertebrate GLD-2 mRNA. We show that the 39-UTR of GLD-2 mRNA elicits its own polyadenylation and translational activation
during frog oocyte maturation. We identify the sequence elements responsible for repression and activation, and demonstrate that
CPEB and PUF proteins likely mediate repression in the resting oocyte. Regulated polyadenylation of GLD-2 mRNA is conserved, as
are the key regulatory elements. Poly(A) tails of GLD-2 mRNA increase in length in the brain in response to neuronal stimulation,
suggesting that a comparable system exists in that tissue. We propose a positive feedback circuit in which translation of GLD-2
mRNA is stimulated by its polyadenylation, thereby reinforcing the switch to polyadenylate and activate batteries of mRNAs.
Keywords: CPEB; GLD-2; PUF; cytoplasmic polyadenylation; poly(A) polymerase

INTRODUCTION
The 39-untranslated region (39-UTR) of mRNAs plays a key
role in controlling nuclear export, localization, translation,
and stability of mRNAs (for review, see Sonenberg 1994;
Hentze 1995; Wickens et al. 2002; Kuersten and Goodwin
2003). Cytoplasmic lengthening of the poly(A) tail increases
translation and mRNA stability, while its removal can cause
translational repression and mRNA decay. These regulated
changes in poly(A) length are critical in early development,
and participate in pattern formation and cell cycle control
(for review, see Richter 2000; Wickens et al. 2000). In the
nervous system, repeated stimulation of synapses activates
polyadenylation and local translation (Wu et al. 1998; Huang
et al. 2002; Si et al. 2003a; Theis et al. 2003), events that
are critical in long-term potentiation (LTP) and learning
(Alarcon et al. 2004). The widespread anatomical distribution of polyadenylation factors suggests that the same system
may operate in many other biological contexts as well.
Meiotic maturation of Xenopus oocytes and mitotic
timing in embryos require cytoplasmic polyadenylation of
cyclin and c-mos mRNAs (for review, see Mendez and
Richter 2001; Wickens et al. 2002). The polyadenylation of
these mRNAs requires elements in their 39-UTRs, including
a uridine-rich cytoplasmic polyadenylation element (CPE)
Reprint requests to: Marvin Wickens, Department of Biochemistry,
University of Wisconsin–Madison, Madison, WI 53706, USA; e-mail:
wickens@biochem.wisc.edu; fax: (608) 262-9108.
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and the hexanucleotide sequence AAUAAA (Fox et al.
1989; McGrew and Richter 1990). CPE-binding protein
(CPEB) binds target mRNAs and elicits their polyadenylation and activation (Hake and Richter 1994). A cytoplasmic
form of cleavage and polyadenylation specificity factor
(CPSF) complex, a multiprotein complex, binds AAUAAA
(Bilger et al. 1994; for review, see Mendez and Richter
2001). Neuronal CPEB is required for polyadenylation of
CPE-containing mRNAs (Wu et al. 1998; Si et al. 2003a)
and is important for formation of hippocampal-dependent
memories (Alarcon et al. 2004; Berger-Sweeney et al. 2006).
CPEB is both an activator and repressor. The inhibitory
function is linked to several other translational repressor
proteins, including maskin, PUF, and Nanos proteins.
Members of each family, along with CPEB, are bound to
specific mRNAs in Xenopus oocytes, and cause their repression prior to meiotic maturation (Stebbins-Boaz et al. 1999;
Nakahata et al. 2001; Cao and Richter 2002; Nakahata et al.
2003; for review, see Richter 2000). These different factors
may repress through redundant mechanisms. Maskin
directly interacts with CPEB and with eIF-4E, preventing
initiation (Stebbins-Boaz et al. 1999; Cao and Richter 2002).
PUF proteins can recruit the Ccr4 complex, containing both
deadenylases and the inhibitory Dhh1p RNA helicase (Goldstrohm et al. 2006). CPEB and PUF proteins are required for
learning (Dubnau et al. 2003) and localize to dendrites (Wu
et al. 1998; Ye et al. 2004; Vessey et al. 2006).
GLD-2, a divergent cytoplasmic poly(A) polymerase
(PAP), was first identified in Caenorhabditis elegans (Wang
et al. 2002). The enzyme is related to the Cid1 and Cid13
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PAPs of Schizosaccharomyces pombe (Read et al. 2002; Saitoh
et al. 2002). GLD-2 enzyme activity is stimulated by
interaction with an RNA-binding protein, GLD-3 (Wang
et al. 2002). Together, GLD-2 and GLD-3 are thought to
form a novel heterodimeric PAP, in which the RNA-binding
component GLD-3 recruits the catalytic subunit GLD-2 to
specific mRNAs (Wang et al. 2002). GLD-2 homologs in
Saccharomyces cerevisiae, Trf4p and Trf5p, localize to the
nucleus. Like GLD-2/GLD-3 in C. elegans, Trf4p’s polymerase
activity is stimulated by RNA-binding proteins Air1p or
Air2p. Trf4p, Air2p, and Mtr4p comprise the TRAMP
complex (Vanacova et al. 2005). In contrast to GLD-2,
however, polyadenylation by this complex leads to RNA
degradation by the nuclear exosome, rather than to activation
(LaCava et al. 2005; Vanacova et al. 2005; Wyers et al. 2005).
GLD-2 poly(A) polymerases were recently identified in
vertebrates, including frogs, mice, and humans (Barnard
et al. 2004; Kwak et al. 2004; Rouhana et al. 2005). The
mouse (mGLD-2) and Xenopus GLD-2 (XlGLD-2) proteins
are both nuclear and cytoplasmic in oocytes (Rouhana et al.
2005; Nakanishi et al. 2006). Cytoplasmic XlGLD-2 protein
is physically associated with CPEB and CPSF (Barnard et al.
2004; Rouhana et al. 2005), but not with CPEB-proteinbound repressors Pumilio and maskin (Rouhana et al. 2005).
Vertebrate GLD-2 proteins are important for meiotic maturation of oocytes, and likely for activation of many mRNAs
throughout early development (Barnard et al. 2004; Rouhana
et al. 2005; Nakanishi et al. 2006). In the mouse brain, GLD-2
mRNA is expressed in anatomical regions necessary for longterm cognitive and emotional learning (Rouhana et al. 2005).
In the hippocampus, mGLD-2 mRNA co-localizes with
CPEB1 and Pumilio1 mRNAs, both of which are involved
in synaptic plasticity. In the cerebellum, mGLD-2 mRNA is
present within the major neuronal cell populations, coincident with the distribution of other CPEB isoforms.
In this study, we focus on the post-transcriptional regulation of GLD-2 mRNA. We show that two previously identified
GLD-2 mRNA isoforms [XlGLD-2A(L) and XlGLD-2A(S)]
differ in their regulation during oocyte maturation. In
particular, the mRNA with a long 39-UTR causes repression
before maturation, then elicits polyadenylation-dependent
activation once maturation begins. This polyadenylationdependent activation of a poly(A) polymerase’s mRNA may
comprise a positive-feedback circuit that reinforces a regulatory switch that supports activation of many mRNAs.
RESULTS
XlGLD-2A(L) 39-UTR causes translational
stimulation during oocyte maturation
The XlGLD-2A gene encodes two mRNAs, termed GLD2A(S) and GLD-2A(L). These mRNAs differ solely in the
length of their 39-UTRs, due to the use of alternative 39-end
cleavage in the nucleus. The long 39-UTR extends an

additional 747 nucleotides (nt) beyond that of the short
form (Fig. 1A,B). The structures and polyadenylation sites
of the two mRNAs were confirmed by isolation of multiple
ESTs, directed RT-PCR, and Northern blotting (data not
shown; Rouhana et al. 2005). The 39-termini of both
mRNA forms are preceded by polyadenylation hexanucleotides, either AAUACA or AAUAAA. A second Xenopus
GLD-2 gene, XlGLD-2B, produces a single mRNA with a
long 39-UTR that is 83% identical to that of XlGLD-2A(L).
Human (hGLD-2) and mouse GLD-2 genes produce two
mRNA isoforms analogous to XlGLD-2A(L) and (S); these,
too, encode identical proteins. The human and frog GLD-2
39-UTRs diverge substantially. Despite only 3% identity
throughout the 39-UTRs, the human 39-UTR contains
islands of sequence conserved in the two frog mRNAs.
For example, the last 32 nt of human and frog mRNAs are
87% identical.
The conserved pattern of isoforms and sequence islands
suggested that the 39-UTRs might have a regulatory role.
To test this hypothesis, we prepared mRNAs in vitro
bearing the luciferase open reading frame (ORF) followed
by either the long or short form of the XlGLD-2A 39-UTR
(Fig. 1C). The mRNAs were injected into the cytoplasm of
Xenopus laevis oocytes. Luciferase activity was determined
after incubation in the absence or presence of progesterone, which induces meiotic maturation. A b-galactosidase
mRNA carrying 15 adenosines was used as an internal
control. Translation of the mRNA bearing the XlGLD2A(L) 39-UTR was stimulated >50-fold during oocyte
maturation (Fig. 1C). The XlGLD-2B 39-UTR stimulated
translation only two- to threefold, while the XlGLD-2A(S)
had no significant effect (Fig. 1C). An mRNA bearing the
cyclin B1 39-UTR, used as a positive control, stimulated
translation z40-fold.
The human GLD-2 gene produces two mRNAs with
different 39-UTRs, analogous in lengths to those of the
Xenopus GLD-2A gene. As mentioned above, the 39-UTR
sequence of the human GLD-2(L) 39-UTR is only 3%
identical to that of the frog GLD-2A(L) 39-UTR overall;
however, both 39-UTRs possess putative CPEs and PUF
protein-binding sites near their 39-termini. To test whether
the 39-UTR of hGLD-2(L) conferred translational regulation,
we injected mRNAs bearing that 39-UTR into oocytes. The
human 39-UTR enhanced luciferase activity 18-fold after
progesterone treatment (Fig. 1D). An mRNA bearing the
XlGLD-2A(S) 39-UTR, used as a control, did not increase
activity. We conclude that despite the great sequence
divergence between the human and frog 39-UTRs, both
specifically stimulate translation during oocyte maturation.
XlGLD-2A(L) is polyadenylated during
oocyte maturation
To determine whether endogenous GLD-2A mRNA was
polyadenylated during oocyte maturation, we determined
www.rnajournal.org
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FIGURE 1. GLD-2 mRNA architecture and activation during oocyte maturation. (A) GLD-2
39-UTRs. Diagram of vertebrate GLD-2 mRNA 39-UTRs and the position of putative
cytoplasmic polyadenylation elements (CPEs; white boxes), PUF binding elements (PBEs;
gray diamonds), and cleavage and polyadenylation specificity sequences (black boxes) are
shown. The last 90 nt of the XlGLD-2A(L) 39-UTR, analyzed in later figures, is indicated by the
black bar over XlGLD-2A(L) mRNA. Regions of high homology with XlGLD-2A(L) sequence
are indicated by the black backbone. (B) XlGLD-2A 39-UTR sequence. The 932-nt sequence of
the XlGLD-2A(L) 39-UTR is presented. The XlGLD-2A(S) 39-UTR sequence is underlined; an
arrowhead indicates the poly(A) addition site of that mRNA. The elements depicted in A are
shown here using the same color key. (C) The XlGLD-2A(L) 39-UTR increases translation of an
mRNA during oocyte maturation. Luciferase reporter mRNAs, bearing different 39-UTRs,
were injected into Xenopus oocytes and incubated overnight in the absence or presence of
progesterone. LacZ mRNA was coinjected as an internal control. Luciferase activity was
measured and normalized to b-galactosidase activity and is shown for progesterone-treated
and untreated oocytes. The ratio of luciferase activity in treated over untreated oocytes is
shown under the X-axis. (D) Elements required for translational stimulation by the XlGLD2A(L) 39-UTR are conserved in the hGLD-2(L) 39-UTR. A luciferase reporter mRNA bearing
the hGLD-2(L) 39-UTR was injected and analyzed as in C.

the length of poly(A) on endogenous XlGLD-2A mRNA
using a PCR-based assay (Fig. 2A; Charlesworth et al.
2004). Total RNA was extracted from X. laevis oocytes at
various times after addition of progesterone. A DNA
oligonucleotide was ligated to the 39-end of the RNA,
and a complementary primer was used to initiate cDNA
synthesis by reverse transcriptase. The primer possessed
190
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four T residues at its 39 terminus, and
thus would detect only polyadenylated
mRNAs. Gene-specific primers in the
39-UTR of the mRNA of interest were
used to prime second-strand synthesis.
After PCR, the lengths of poly(A) tails
were deduced from the length of DNA
fragments.
The poly(A) tails of endogenous
XlGLD-2A(L) mRNA became progressively longer at successive times during
oocyte maturation (Fig. 2B); after 6 h,
the tails had been extended by 150–200
adenosines. In contrast, the poly(A) tails
of XlGLD-2A(S) mRNA did not appear
to change in length during maturation
(Fig. 2B), consistent with the lack of
translational stimulation by that mRNA’s
39-UTR (Fig. 1C). As controls, the
poly(A) tails of cyclin B1 mRNA were
extended by z150 residues, while polyadenylated forms of ribosomal proteinL1 mRNA apparently disappeared, as
expected (Fig. 2B). We conclude that
polyadenylation of the endogenous
mRNAs mirrors the translational properties of the 39-UTR reporters, and that
endogenous XlGLD-2A(L) mRNA is
polyadenylated during maturation.
Polyadenylation of XlGLD-2A(L)
mRNA is specific, as it was not observed
with other mRNAs, including ones
involved in translational control during
maturation (Fig. 2C). The poly(A) tails
of CPEB, CPSF-160, CPSF-100, PABP-1,
Xcat-2, maskin, and Xp54 mRNAs were
not dramatically different before and
after maturation. Xp54, maskin, and
CPSF-73 mRNAs appeared to undergo
transient polyadenylation, during or
after germinal vesicle breakdown, but
were later deadenylated (Fig. 2C). The
multiple bands observed with PABP-1
mRNA reflect different 39-UTR lengths,
consistent with cDNA and EST databases.

GLD-2 control is mediated by CPE- and
AAUAAA-dependent cytoplasmic polyadenylation
To identify the sequence elements in XlGLD-2A(L) mRNA
that promote its translational activation, we first analyzed
the roles of CPEs and the polyadenylation signal AAUAAA.
Both of these elements are conserved in the long isoforms
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FIGURE 2. Polyadenylation of endogenous XlGLD-2A(L) mRNA during oocyte maturation.
(A) Measurements of poly(A) length. Total RNA from Xenopus oocytes, maturing oocytes, and
eggs was ligated to the 59-end of a modified DNA oligo. Reverse transcriptase was used to
synthesize DNA complementary to the mRNA, using a primer anti-sense to the ligated DNA
oligonucleotides; this newly synthesized DNA contained the poly(A) tail region. A genespecific primer, along with a primer anti-sense to the ligated DNA oligo, was used to amplify
the 39-end of the gene of interest by PCR. The lengths of PCR products from gene-specific
primers were determined using 2.5% agarose gels. (B) XlGLD-2A(L) is polyadenylated during
oocyte maturation. mRNA was prepared at the indicated times after addition of progesterone
or from unfertilized eggs. To determine poly(A) lengths of each endogenous mRNA, reactions
were performed using primers specific for each of the four indicated mRNAs. The lengths of
products obtained in resting oocytes were consistent with the known ends of the mRNA. The
PCR products of XlGLD-2A(L) and cyclin B1 show slower electrophoretic mobility during
maturation, indicating that those mRNAs are polyadenylated during maturation. The PCR
products obtained with XlGLD-2A(S) and ribosomal protein L1 primers do not increase in
length, indicating that these mRNAs are not polyadenylated. (C) Analysis of mRNAs encoding
factors involved in translational regulation during oocyte maturation. The poly(A) tail of
mRNAs for CPEB, CPSF-160, CPSF-100, CPSF-73, PABP-1, Xcat-2, and maskin were analyzed
during oocyte maturation, using the same protocol as in A and B. The lengths of the specific
39-end fragments, as determined by EST analysis, are indicated with arrowheads.

of GLD-2 mRNA in vertebrates (Fig. 1A). We focused on
the last 90 nt of the XlGLD-2A(L) 39-UTR because it
stimulated translation during maturation as efficiently as
the full-length XlGLD-2A(L) 39-UTR and is highly conserved between Xenopus and humans. The conservation
includes tandem CPEs and AAUAAA (Fig. 3A), and the
spacings between them (data not shown).

Mutant forms of the 39-UTR linked
to the luciferase ORF were injected into
oocytes, which were then induced to
mature using progesterone (Fig. 3B).
mRNAs with mutations in either CPE
alone did not perturb translational
stimulation; however, simultaneous
mutations in both CPEs decreased stimulation substantially, as did a point
mutation in AAUAAA (Fig. 3B). We
conclude that the two CPEs act redundantly, and in concert with AAUAAA,
to promote translational activation.
To assess polyadenylation of these
RNA sequence variants directly, we
injected short, radiolabeled RNAs
encoding a 21-amino acid-long microORF linked to each terminal 39-UTR
segment. The 32P-labeled mRNAs,
extracted from oocytes after overnight
treatment with or without progesterone, were analyzed by electrophoresis
(Fig. 3C). RNAs containing the wildtype sequence of the XlGLD-2A(L) 39UTR increased by z150 nt in length
after oocyte maturation (Fig. 3C, lanes
1–3), consistent with the length of
poly(A) added to the endogenous
mRNA (Fig. 2B). mRNAs that lacked
both CPE1 and CPE2 were much less
active as substrates (Fig. 3C, lanes 4–6).
Mutation of AAUAAA essentially abolished polyadenylation (Fig. 3C, lanes
7–9). Thus the sequence specificities of
translational activation and polyadenylation are similar.

GLD-2 protein is bound to XlGLD2A(L) mRNA in Xenopus oocytes

The GLD-2 enzyme catalyzes polyadenylation of certain mRNAs during
oocyte maturation and acts in collusion
with CPEB and CPSF (Barnard et al.
2004; Rouhana et al. 2005; Nakanishi
et al. 2006). We reasoned that GLD-2
protein might polyadenylate GLD-2
mRNA. To test whether XlGLD-2A(L) mRNA was bound
to GLD-2 protein, we incubated oocyte lysates with antiGLD-2 antibodies, extracted immunoprecipitated RNAs,
and analyzed them by semiquantitative RT-PCR (Fig. 4).
XlGLD-2A(L) mRNA was readily detected in immunoprecipitates obtained with a-GLD-2, but not with control,
pre-immune antibodies (Fig. 4). cyclin B1 mRNA, used as a
www.rnajournal.org
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CPEs and PUF-binding elements are required for
repression of GLD-2 mRNA

FIGURE 3. Translational stimulation by the XlGLD-2A(L) 39-UTR is
due to CPE-dependent polyadenylation. (A) Mutational analysis of
the last 90 nt of the XlGLD-2A(L) 39-UTR. The RNA sequence of the
last 90 nt of the XlGLD-2A(L) 39-UTR and of mutant 39-UTRs. Two
CPEs (UUUUA; white boxes) in this region were mutated into CArich sequences, either individually (CPE1 and CPE2 ) or together
(CPE1 CPE2 ). The cleavage and polyadenylation specificity hexanucleotide sequence AAUAAA (black box) was mutated to AAgAAA.
Mutated elements are highlighted with dashed boxes. (B) The last
90 nt of the XlGLD-2A(L) 39-UTR increases translation during oocyte
maturation, in a CPE- and AAUAAA-dependent manner. Luciferase
reporter mRNAs carrying the last 90-nt sequence of XlGLD-2A(L),
and the mutations indicated in A, were injected into Xenopus oocytes
and incubated overnight in the absence or presence of progesterone.
Luciferase activity was measured and normalized to the co-injected
b-galactosidase mRNA, as described in Figure 1C. Translational stimulation of luciferase by the wild-type sequence was set as 100%. (C)
XlGLD-2A(L) undergoes CPE- and AAUAAA-mediated cytoplasmic
polyadenylation. 32P-labeled mRNAs, containing a mini-ORF and the
indicated 39-UTRs, were injected into Xenopus oocytes and incubated
overnight in the absence ( ) or presence (+) of progesterone. ‘‘Input’’
lanes are the RNA immediately after injection. mRNAs were extracted
and analyzed for changes in electrophoretic mobility in a 6% polyacrylamide gel. (Lanes 1–3) Wild-type XlGLD-2A(L) sequence was
polyadenylated in response to progesterone treatment (average
An = 150). mRNAs with mutated (lanes 4–6) CPEs (CPE1 CPE2 )
or (lanes 7–9) AAUAAA element (AAgAAA) showed reduced
polyadenylation.

positive control, was also enriched in a-GLD-2 immunoprecipitates (Fig. 4; Rouhana et al. 2005). Xfin, an
mRNA that undergoes deadenylation during oocyte maturation (Ruiz i Altaba et al. 1987; Fox and Wickens 1990),
was not specifically immunoprecipitated by a-GLD-2, as
it was absent in both the a-GLD-2 and pre-immune
immunoprecipitates (Fig. 4). We conclude that XlGLD2A(L) mRNA is bound by GLD-2 protein in Xenopus
oocytes.
192
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The last 90 nt of XlGLD-2A(L) contains four putative PUFprotein-binding elements (PBEs), as does GLD-2 mRNA in
Xenopus tropicalis (Fig. 5A). Mouse and human GLD-2(L)
mRNAs possess a single PBE in the same location as PBE2
(Fig. 5A). To determine whether PBE2 bound Xenopus
Pumilio, we performed gel retardation assays using purified
recombinant GST-Xl Pumilio (Fig. 5B). The protein bound
to both PBE2 and the NRE (derived from hunchback
mRNA). Binding was specific, since it was reduced by at
least an order of magnitude by mutation of the UGU to
ACA, as expected for a PUF interaction (Fig. 5B; e.g.,
Bernstein et al. 2005).
Both CPEB and PUF proteins can inhibit translation of
mRNAs to which they bind. To test whether the CPEs or
PBEs of XlGLD-2A(L) mRNA repressed its translation, we
prepared luciferase mRNAs linked to mutant and wild-type
39-UTRs (Fig. 6A). For repression studies, we prepared
mutant mRNAs containing mutations in either all four
putative PUF-binding elements (PBE1–4) or both CPEs
and a third degenerate CPE. The degenerate CPE was
included because it partially overlaps PBE2 and because
residual polyadenylation was detected with a 39-UTR
carrying mutations in the first two CPEs (Fig. 3C, lanes
4–6). These mRNAs were injected into resting oocytes,
without progesterone treatment. The mRNA that carried
CPE mutations was translated ninefold more efficiently
than a wild-type mRNA, suggesting that these CPEs repress
translation of GLD-2 mRNA prior to maturation. Repression by the CPEs was dose-dependent: it was observed at

FIGURE 4. GLD-2 protein is bound to XlGLD-2A(L) mRNA. Oocyte
extracts were incubated with a-GLD-2 or pre-immune guinea pig
serum and bound to Protein A–Sepharose. RNA was extracted and
used as a template for reverse transcription. mRNAs were detected by
semiquantitative PCR on cDNA with gene-specific primers. XlGLD2A(L) mRNA is detected in RNAs immunoprecipitated by a-GLD-2,
but not by pre-immune serum. The lengths of products are consistent
with the known 39-termini of the mRNAs.
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FIGURE 5. Xenopus Pumilio binds to PBEs in the GLD-2(L) 39-UTR.
(A) A highly conserved region of the GLD-2(L) 39-UTR contains
multiple PBEs. Putative PBEs (PBE1-4 for Xenopus GLD-2; gray
boxes) and cleavage and polyadenylation hexanucleotides (black
boxes) in GLD-2(L) mRNAs. The chemically synthesized RNA used
for xPum/RNA-binding assays is indicated by the black rectangle on
the XlGLD-2A(L) sequence. (B) Binding to purified PUF protein.
Various concentrations of purified, recombinant GST-xPum were
incubated with labeled RNAs in vitro and analyzed by electrophoretic
mobility shift assays. The RNAs correspond to the NRE of hunchback
mRNA, PBE2, and a mutant form of PBE2 in which the UGU has
been changed to ACA. The protein concentrations were 10 nM, 25 nM,
50 nM, 100 nM, 270 nM, and 810 nM.

low (2 fmol per oocyte) but not high (20 fmol per oocyte)
concentrations, consistent with earlier reports that CPEmediated repression is saturable (Fig. 6B,C; Barkoff et al.
2000; Cao and Richter 2002). An mRNA bearing mutations
in all four PBEs also was de-repressed in the resting oocyte,
yielding four- to sixfold more luciferase than the wild-type
mRNA. This effect was not dose dependent (Fig. 6B,C).
The CPEs in the XlGLD-2A(L) 39-UTR also are required
for translational activation once progesterone is added.
mRNAs that lacked CPEs (injected at 2–3 fmol per oocyte)
did not increase in activity significantly during maturation
(Fig. 6D,E). In contrast, PBE mutant mRNAs did increase
in activity in the same period (Fig. 6D,E). The magnitude
of stimulation (the ratio of activities with and without
progesterone) was less with the PBE mutant than with the
wild type; this difference arises because the PBE mutations
increased the ‘‘basal’’ level of translation prior to maturation. We conclude that both CPE- and PBE-dependent
mechanisms repress XlGLD-2A(L) mRNA prior to maturation. The CPEs are required to stimulate expression
during maturation, while the PBEs are not.
Polyadenylation in resting oocytes
Mutations in either the CPEs or the PBEs increase translation in oocytes prior to maturation (Fig. 6). To assay
polyadenylation of these RNAs sensitively, we extracted
total RNA from oocytes 4 h after injection and performed
PCR-based poly(A) length assays as in Figure 2. An
oligonucleotide was first ligated to the total RNA. To

FIGURE 6. CPE- and PBE-mediated repression of the XlGLD-2A(L)
39-UTR. (A) Mutational analysis of the last 90 nt of the XlGLD-2A(L)
39-UTR. Wild-type sequence of the last 90 nt of the XlGLD-2A(L)
39-UTR is shown on the top line. CPE1, CPE2, and a downstream
degenerate CPE (white boxes) were mutated to generate 3xCPE .
Four putative PBEs (gray boxes) in this region were mutated to
generate 4xPBE . The second PBE and the degenerate CPE sequences
overlap; the mutations were designed to abolish one or the other
element in isolation. Mutated elements are highlighted with dashed
boxes. (B) PBEs and CPEs of the XlGLD-2A(L) 39-UTR repress
translation in the oocyte. Luciferase reporter mRNAs carrying the
39-UTRs shown in A were injected at 2 fmol of RNA per oocyte
and incubated overnight at room temperature. Luciferase activity was
measured and normalized to b-galactosidase activity, as in Figure 1C.
The luciferase/b-galactosidase ratio of the reporter carrying the wildtype 39-UTR was set to 1 for normalization. (C) Repression by CPEs,
but not PBEs, is abolished at high mRNA concentrations. mRNAs
described in A were injected at 10-fold higher concentration than in
Figure 6B (20 fmol per oocyte), and tested for their effect on luciferase
translation. (D) Translational stimulation during oocyte maturation
requires CPEs, but not PBEs. The luciferase reporter mRNAs
indicated above were injected at 2 fmol per oocyte and incubated at
room temperature in the presence or absence of progesterone.
Luciferase and b-galactosidase measurements were taken at the time
points indicated. The ratios of luciferase/b-galactosidase activities in
progesterone treated versus untreated oocytes are plotted on the
Y-axis. (E) Translational stimulation during oocyte maturation requires
CPEs, but not PBEs. The luciferase reporter mRNAs indicated in A
were injected at 2–3 fmol per oocyte and incubated overnight in the
presence or absence of progesterone. Luciferase and b-galactosidase
activities were measured and normalized as indicated for Figure 1C.
The activities of wild-type and 4xPBE mRNA increased with
progesterone treatment, and both mRNAs were translated at similar
levels in mature oocytes (+P). The activity of the 3xCPE mRNA was
higher in untreated oocytes, but significantly lower than wild-type and
4xPBE mRNAs in mature oocytes.
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specifically detect polyadenylated mRNAs, we used a
primer complementary to the ligated oligonucleotide plus
15 39-terminal thymidine residues. Surprisingly, in resting
oocytes, both wild-type and PBE mutant mRNAs were
polyadenylated. Roughly 40 adenosines were added to the
wild-type mRNA and 50 to the PBE mutant mRNA (Fig. 7,
lanes 1,2). The length of poly(A) on endogenous XlGLD2A(L) mRNA is comparable (see Fig. 2B). This polyadenylation reaction was largely CPE dependent (Fig. 7, lane 3).
As a control, we used a primer that was complementary to
the ligated primer, but without an oligo(dT) segment. With
this primer, the products obtained correspond in majority
to nonadenylated mRNAs: wild-type and mutant mRNAs
yielded identical distributions of PCR products, as
expected. Together, these observations suggest that
XlGLD-2A(L) mRNA, prior to maturation, receives a
poly(A) tail of limited length. This polyadenylation event
is detected on a minority of molecules. We conclude that
CPE-mediated polyadenylation occurs in oocytes prior to
maturation. This ‘‘resting polyadenylation’’ reaction is
counteracted in part by PBEs, presumably acting through
the Xenopus PUF protein.
GLD-2 expression and polyadenylation in the brain
In the nervous system, translation of dendritically localized
mRNAs is enhanced upon synaptic stimulation and is
thought to require cytoplasmic polyadenylation (Si et al.
2003a). We reasoned that GLD-2 mRNA itself might be
regulated by polyadenylation in the brain. The components
of the regulatory machinery—GLD-2, CPEB, and PUF
proteins—co-localize at the mRNA level in the hippocampus, cerebellum, and olfactory bulb of the mouse brain
(Rouhana et al. 2005). To detect the tissue distribution of

FIGURE 7. CPE-dependent polyadenylation in resting oocytes. Wildtype, 4xPBE , and 3xCPE mutant mRNAs were injected into resting
oocytes. mRNA from oocytes injected with the reporters shown in
Figure 6A was analyzed using the PCR-based poly(A) length assay
(Fig. 2A). Reverse transcription and PCR were performed with a
primer selective for poly(A) tails [oligo+p(dT)15; lanes 1–3] revealed
longer tails for the 4xPBE mRNA than for wild-type mRNA (lanes
1,2). The poly(A) tail length of 3xCPE mRNA is minimal (lane 3).
The background signal from oocytes not injected with reporter mRNA
is shown (lane 4). The polyadenylation difference is not observed
when using an oligo that is not selective for mRNAs with a poly(A)
tail [oligo+p(dT)0; lanes 5–7].
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GLD-2 protein in Xenopus, we extracted total protein from
various tissues, including dissected subregions of the brain,
and detected GLD-2 by Western blotting with affinitypurified a-GLD-2 antibodies. GLD-2 was most abundant
in medulla, spinal nerve, cerebellum, and cerebrum (Fig. 8A).
It was present at lower levels in other somatic tissues,
including liver, heart, and muscle. a-Actin antibodies
served as a loading control.
To determine whether brain XlGLD-2A(L) mRNA was
polyadenylated after neuronal stimulation, we examined its
polyadenylation state after treating intact animals with
kainic acid. Kainic acid, a seizure-inducing agent, dramatically stimulates neuronal activity (Watkins and Evans
1981). Male frogs were injected with kainic acid, which
induced tremors, as expected; injections of saline were used
as controls. After 45 min, the cerebellum was dissected. The
lengths of poly(A) on GLD-2 mRNA were determined using
the PCR-based assays described previously. As expected, the
lengths of poly(A) on XlGLD-2A(L) mRNA were heterogeneous both with and without kainic acid, ranging from z50
to 200 nt (Fig. 8B,C). However, the average poly(A) tail
length for XlGLD-2A(L) mRNA increased in response to
kainic acid and included a new discrete species of z220
residues (Fig. 8B,C). The poly(A) tails of PABP-1 mRNA,
used as a control, were homogeneous (z30 adenosines) and
were unaffected by kainic acid treatment (Fig. 8B).
To ensure that the heterogeneous PCR products were
derived from XlGLD-2A(L) and contained poly(A), we
exploited a BsrG1 restriction enzyme site located at the
39-most end of the XlGLD-2A(L) 39-UTR (Fig. 8D,
diagram). Treatment of the GLD-2 PCR products with
BsrG1 transformed the heterogeneous population into a
homogeneous-sized DNA of the predicted length, showing
that the PCR products were, indeed, derived from the
XlGLD-2A(L) 39-UTR (Fig. 8D). To determine whether the
heterogeneity was due to heterogeneity in poly(A) tails, we
performed primer extension analysis of the GLD-2 PCR
products in the presence of dATP, dTTP, dCTP, or dGTP
(Fig. 8E). The primer, which was complementary to the
ligated oligonucleotide, was extended only in the presence
of dTTP, corresponding to poly(A) tails in the mRNA
(Fig. 8E). We conclude that the poly(A) tails of XlGLD2A(L) mRNA in the brain increase in length after kainic
acid treatment. These data suggest that GLD-2 mRNA is
selectively polyadenylated after neuronal stimulation, as in
oocytes; however, it remains possible that the increase in
poly(A) length after stimulation reflects new transcription
of mRNAs with longer tails, or inhibition of deadenylation.
DISCUSSION
XlGLD-2A(L) mRNA is repressed in the oocyte, then
polyadenylated and activated during maturation. This
process is conserved, since the human GLD-2(L) 39-UTR
behaves comparably (Fig. 1) and mouse GLD-2 mRNA is
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FIGURE 8. Poly(A) tail length of neuronal GLD-2(L) mRNA increases upon stimulation. (A) Western blot analysis of GLD-2 protein in tissues of
frog brain, spinal nerve, liver, heart, and muscle. GLD-2 protein was enriched in tissues of the nervous system (top), but was also seen expressed in
other tissues after longer exposures (middle). Actin was also analyzed as a loading control (bottom). (B) The XlGLD-2A(L) poly(A) tail is increased
in response to kainic acid in frog brain. PCR-based poly(A)-length assay (performed as in Fig. 2) on cerebellar RNA from kainic acid treated and
untreated frogs. High resolution was obtained by 32P-end-labeling of DNA products and electrophoresis in a 6% polyacrylamide gel. (C) Poly(A)length distribution for XlGLD-2A(L) was created from PhosphorImager scans for the kainic acid treated and untreated PCR-based poly(A)-length
measuring assay. (D) Heterogeneous XlGLD-2A(L) PCR products from poly(A) length analysis due to different lengths at 39-ends. XlGLD-2A(L)
DNA products from the poly(A)-length assay were digested with BsrG1, whose substrate sequence is present downstream from the AAUAAA
hexanucleotide on XlGLD-2A(L). The BsrG1 digest creates a homogeneous 200-nt product, as is expected from the XlGLD-2A(L) UTR sequence.
(E) Primer extension analysis confirms heterogeneity of XlGLD-2A(L) poly(A) lengths. A 32P-labeled DNA oligonucleotide anti-sense to the
oligonucleotide ligated to the end of the mRNA was used for primer extension analysis of XlGLD-2A(L) and PABP-1 PCR products. Primer
extensions were performed in the presence of one of dATP, dTTP, dCTP, or dGTP. Primers were extended only in the presence of dTTP,
indicative of poly(A) at the end of both XlGLD-2A(L) and PABP-1 substrates. The XlGLD-2A(L) products were extended by 50–300 residues in
the presence of dTTP, while PABP-1 products were extended by 20–30 residues. These lengths are consistent with the measurements in B.

polyadenylated during oocyte maturation (Nakanishi et al.
2006). CPEs and AAUAAA are required for polyadenylation of GLD-2 mRNA and for the increase in translational
activity during maturation; this implies that GLD-2 polyadenylates its own mRNA, presumably via protein–protein
interactions with CPSF and CPEB (Barnard et al. 2004;
Rouhana et al. 2005). Indeed, GLD-2 protein is bound to
its own mRNA in the resting oocyte (Fig. 4). A similar
circuit may exist in the brain, since the poly(A) tails of
XlGLD-2A(L) mRNA increase in length in response to the
brain in response to neuronal stimuli.
We propose that a positive feedback circuit activates and
sustains GLD-2 protein, both during oocyte maturation and
in response to synaptic stimulation (Fig. 9). This circuit
would enhance translation not only of XlGLD-2A(L), but
also of its other, CPE-containing mRNA targets on which

GLD-2 acts. In the nervous system, GLD-2 autoactivation
may complement the CPEB prion switch (Si et al. 2003b).
The GLD-2(L) mRNA isoform is particularly abundant
in mouse and human brains (Rouhana et al. 2005). Other
tissues, such as pituitary gland, heart, placenta, ovary, testis,
liver, spleen, and kidney; possess abundant GLD-2(S) as
well as GLD-2(L) mRNA (Rouhana et al. 2005). The
preponderance of the long form in the brain may reflect
the requirement for regulation in that tissue.
Alternative 39-UTRs in certain other mRNAs also mediate developmental, physiological, and pathological controls
(for review, see Hughes 2006). For example, an alternative
39 exon in the Drosophila elav gene generates a longer
39-UTR that is autoregulated by ELAV protein (Borgeson
and Samson 2005). Alternative 39-end formation is often conserved and tissue-specific (for review, see Edwalds-Gilbert
www.rnajournal.org
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FIGURE 9. Working model: a positive feedback loop activates GLD-2
mRNA. In the ‘‘off’’ state, translation of GLD-2 mRNA is repressed via
PUF and CPEB, bound to specific sites in the long 39-UTR isoform of
GLD-2A mRNA. The bound PUF protein promotes removal of the
tail, as suggested by the measurements of poly(A) length on PBE
mutant mRNAs. GLD-2 protein also is bound to the mRNA and
modestly promotes poly(A) lengthening prior to maturation. The net
result is that the poly(A) tail of the mRNA is short. The PUF and
CPEB proteins may also repress by deadenylation-independent
mechanisms not depicted in the figure. After stimulation, GLD-2
mRNA is de-repressed and becomes a substrate for CPE-mediated
polyadenylation by GLD-2 cytoplasmic PAP. The ability of GLD-2 to
polyadenylate its own mRNA creates a positive feedback mechanism
for the polyadenylation of this (and other) CPE-encoding mRNAs.

et al. 1997; Tian et al. 2005; Zhang et al. 2005). Longer
brain-specific 39-UTRs have been reported for the Huntington disease gene, beta-adducin, and mCPEB3 (Lin et al. 1993;
Theis et al. 2003; Costessi et al. 2006). Recently, a genomewide study suggested differential repression of transcripts with
alternative 39-UTRs by microRNAs (Legendre et al. 2006).
The differential control imposed by alternative 39-UTRs, as
seen with GLD-2 mRNA, may be common.
The addition of poly(A) in resting oocytes, observed here
for the first time, may be catalyzed by previously reported
complexes containing CPEB, CPSF, and GLD-2 (G complexes) (Rouhana et al. 2005). Indeed, this polyadenylation
process is CPE dependent and partially counteracted by
PBEs. Only a short tail is added prior to maturation,
suggesting that either the addition process is blocked or
that a deadenylase compensates and balances the tail
length, as suggested during oocyte maturation (Fox et al.
1989; Varnum and Wormington 1990).
The presence of two comparable isoforms of GLD-2
mRNA in frog, mice, and humans suggests a conserved
difference in the function of short and long GLD-2 mRNAs.
Here we have shown that in Xenopus, the long isoform of
XlGLD-2A is polyadenylated during oocyte maturation; the
short isoform is not. CPEs, presumably acting through CPEB,
inhibit translation of XlGLD-2A(L) (Cao and Richter 2002);
PBEs may effect poly(A) tail length through a PUF–
deadenylase interaction (Goldstrohm et al. 2006). Both mechanisms would prevent translation of XlGLD-2A(L) mRNA
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until stimulation occurs. Once polyadenylation did occur,
GLD-2 protein would then polyadenylate its own GLD-2(L)
mRNA, creating a positive feedback cascade (Fig. 9). The
short isoform of mRNA may contribute a low level of latent
poly(A) polymerase, whose activation initiates the cascade.
The level of total GLD-2 protein detected by a-GLD-2
antibodies does not change significantly during maturation
(data not shown). This might be due to the fact that GLD2A(L) mRNA is repressed in the resting oocyte, while GLD2A(S) and GLD-2B mRNAs are readily translatable (Fig. 1C).
It is possible that the protein accumulated from GLD-2A(S)
and GLD-2B mRNAs during oogenesis obscures the newly
synthesized protein produced from activation of GLD-2A(L)
mRNA during oocyte maturation, as analyzed by Western
blotting. Direct measurements of the relative contributions
of GLD-2A and GLD-2B proteins to the total GLD-2 in an
oocyte have not been possible. The GLD-2 polyadenylation
circuit may be conserved in part because of its role in other
tissues. The initial switch in the circuit may involve
activation of latent GLD-2 protein, perhaps produced from
the GLD-2A(S) or GLD-2B isoforms. It is unclear why the
39-UTR of XlGLD-2B is largely inactive, despite its high
sequence similarity to that of XlGLD-2A(L).
The positive feedback circuit may be reinforced at
multiple levels to achieve a sustained and robust switch
in polyadenylation activity. Many mRNAs that undergo
cytoplasmic polyadenylation during oocyte maturation
encode factors involved in protein phosphorylation cascades (e.g., protein kinases Cdk-2, c-mos, Wee1, FGFR1,
and Eg2; and cyclins A1, B1, B2, and B4) (Sheets et al. 1994;
for review, see Wormington 1994; Stebbins-Boaz et al.
1996; Charlesworth et al. 2004). Polyadenylation of GLD-2
mRNA presumably serves as the upstream activator of the
cascade, turning on the translation of these mRNAs, as well
as its own. Interestingly, GLD-2 protein activity is regulated
in part by the targets it controls, as Eg2, whose mRNA is
regulated by polyadenylation (Charlesworth et al. 2004),
phosphorylates CPEB and thereby enhances polyadenylation (Mendez et al. 2000a,b). At synapses, CaMKII mRNA
undergoes CPEB-protein-mediated polyadenylation (Wu
et al. 1998) and CaMKII protein phosphorylates CPEB
(Atkins et al. 2004). The robustness of the switch may be
critical both in development and in the nervous system.
In oocytes, once polyadenylation is activated, the system
maintains that state and leads to polyadenylation of
batteries of mRNAs. GLD-2, CPEB, and PUF proteins act
in concert to establish that circuit.
MATERIALS AND METHODS
DNA constructs
pLG-CB1
pLG-MS2 (Gray et al. 2000) was digested with SpeI and BglII, in
order to remove the MS2 sequence, blunt ended with Klenow
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DNA polymerase (Promega), and re-ligated. This construct is
used for transcription of the luciferase-cyclinB1 39-UTR.
pLuci-XlGLD-2A(L)
The XlGLD-2A(L) 39-UTR was amplified from IMAGE:6638921
using primers CAGCACTAGTACTAGTACTGGAATCTGCAGA
GAAATAC and ACAGGATCCGGATCCGTACATACATTTTAT
TCCATTCAACATCAT, digested with SpeI and BamHI, and
ligated into SpeI- and BamHI-digested pLG-MS2. This construct
is used for transcription of the luciferase-XlGLD-2A(L) 39-UTR.
pLuci-XlGLD-2A(S)
The XlGLD-2A(S) 39-UTR was amplified from IMAGE:6638921
using primers CAGCACTAGTACTAGTACTGGAATCTGCAGA
GAAATAC and ACAGGATCCGGATCCGGTTCAATATTTGTA
TTTAAAC, digested with SpeI and BamHI, and ligated into
SpeI- and BamHI-digested pLG-MS2. This construct is used for
transcription of the luciferase-XlGLD-2A(S) 39-UTR.
pLuci-XlGLD-2B
The XlGLD-2B 39-UTR was amplified from IMAGE:6643643
using primers CAGCACTAGTACTAGTACTGGAATCTGCAGA
GAAATAC and ACAGGATCCGGATCCGGTACATACATTTTA
TTCCATTCAACACC, digested with SpeI and BamHI, and ligated
into SpeI- and BamHI-digested pLG-MS2. This construct is used
for transcription of the luciferase-XlGLD-2B 39-UTR.
pLuci-hGLD-2(L)

pLR9 series
The wild-type 39-most 90-nt sequence from XlGLD-2A(L) (as well
as mutations describe in Figs. 3A, 6A), were oligo-cloned into
SpeI- and BamHI-digested pLG-MS2. This series of constructs is
used for transcription of the luciferase last 90 nt of the XlGLD2A(L) 39-UTR (and mutations thereof).

The pT7-LR9 series is a series of clones
based on the pLR9 series, but with removal
of most of the luciferase ORF, created by
blunt-end ligation and cloning. This series of
constructs is used for transcription of a
mini-ORF with the last 90 nt of the
XlGLD-2A(L) 39-UTR (and mutations
thereof; see Fig. 3A).
pJK350 (b-galactosidase)
This construct was previously described
(Gray et al. 2000).

The pLG-CB1, pLuci-XlGLD-2A(L), pLuci-XlGLD-2A(S), pLuciXlGLD-2B, pLuci-hGLD-2(L), pLR9 series, and pT7-LR9 series
constructs were cleaved with BamHI and transcribed with T7
RNA polymerase. Transcriptions were performed in the presence
of 6 mM m7GpppG. In some cases, [a-32P]UTP was incorporated
during in vitro transcription as described (Dickson et al. 2001).

mRNA injection and manipulation of
Xenopus oocytes
Oocyte removal, injection, and the induction of meiotic maturation were performed as previously described (Ballantyne et al.
1997). mRNAs were injected at either 2–3 fmol/50 nL, or 20–30
fmol/50 nL for the luciferase reporter mRNAs, along with 12 fmol/
50 nL for the b-gal reporter mRNA.

Extraction and analysis of mRNAs from oocytes
Total RNA was extracted from frog tissues using 10 oocytes, or
eggs, per 1 mL of TRI reagent (Sigma) following the manufacturer’s
protocol. After ethanol precipitation, the RNA was solubilized in
10 mL of DEPC-treated water, and either used for the PCR-based
poly(A)-length assay, or loaded to a 6% polyacrylamide gel (short
32
P-labeled RNAs) and analyzed by autoradiography.

Luciferase and b-galactosidase measuring assay
These assays were performed as described by Gray et al. (2000).

PCR-based poly(A)-length measuring assay

The hGLD-2(L) 39-UTR was amplified from IMAGE:4824607
using primers CAGCACTAGTACTCTGGCCTCTATTTCTTAA
TAAATTCTTCC and CGGATCCGGATCCGTCCATATATAAAT
TTTATTGCATTTGACATC, digested with SpeI and BamHI, and
ligated into SpeI- and BamHI-digested pLG-MS2. This construct
is used for transcription of the luciferase-hGLD-2(L) 39-UTR.

pT7-LR9 series

In vitro transcription

This technique was performed as described by Charlesworth et al.
(2004). Briefly, 4 mg of oocyte (or 2 mg of brain) total RNA was
ligated to 0.4 mg of a 39-amino-modified DNA anchor primer
(Operon). The ligated products were then reverse-transcribed
using a primer anti-sense to the anchor primer plus four thymidine residues on its 39-end, using Superscript II (Invitrogen).
Two microliters of this reaction were used as a template for
gene-specific PCR, using the primers listed in Table 1, and the
primer anti-sense to the anchor primer, used in the reversetranscriptase reaction (unless specified differently). The annealing
temperature was 56°C for all genes except for CPSF-73, for which
the annealing temperature was 48°C. DNA products from the

TABLE 1. Oligonucleotides used in PCR-based poly(A)-length assay
gld2aL_2485
gld2aS_post-stop SpeI
cycB1_1072
L1_1033
cpeb_2975
maskin_2896
Xcat2_2661
pabp1_2281
cpsf100_3084
cpsf73_1993
cpsf160_D
Luciferase polylinker

CAATTAAGGCACAATCTGGTGTCTTTG
CAGCACTAGTACTAGTACTGGAATCTGCAGAGAAATAC
GGTCCCTGTTATGCAGCATATGGCC
GCTGAACCCATATGCAAAGACCGC
CTTCCTAGCTGCCCTAAGCAG
GGAGAAGATCTGACCCACTGAGGTGG
GGACATTCCAGCTCTCAAGAGACGC
GTGCCAACTGCTTAAGATGCATGC
TCGCAGCCTCCCTCATAGGGG
GAGGAAGGAATCGATGAGG
CTGTTACCCCACCATGCCGGACTCAACCCC
ACCTCTCTCTCTCTCTCAGGGCTGATTACTAG
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brain XlGLD-2A(L) PCR-based poly(A)-length measuring assay,
were end labeled with T4 Polynucleotide Kinase (Promega) and
[g-32P]ATP.

RNA coimmunoprecipitation
Coimmunoprecipitation and extraction of RNA with a-GLD-2
antibodies were performed as described previously (Rouhana et al.
2005). cDNA was made from total and coimmunoprecipitated
oocyte RNA by oligo-coupled reverse transcription with Superscript II (Invitrogen). One-twentieth of the reverse-transcription
reaction was used as a template for gene-specific PCR. Oligos
GCAGGTTTGCGCTTGAGAAAATGTCAC and GGAGGAAGCA
GCTGCTATTTGGGAAGGCG were used as primers for cyclin B1;
GCTGCCTATTTAATACTTATCCATGAG and CAAAGACAC
CAGATTGTGCCTTAATTG for XlGLD-2A(L); and CATTGA
CCGCTCATCAGTTGTC and CAGAGCGACTTCAGAAATCCA
ACC for Xfin.

Electrophoretic mobility shift assays
GST-fused Xenopus Pumilio (amino acids 824–1185) was purified
as described for GST-FBF-2 (Bernstein et al. 2005) and combined
with 100 fMol of 32P-end-labeled RNA oligoribonucleotides
(Integrated DNA Technologies). The shift conditions and binding
constants were calculated as described by Hook et al. (2005).

Kainic acid treatment and brain RNA extraction
Kainic acid was administered to males (15 mg/kg) via subcutaneous injection in the lymph sac. Sterile saline (pH 7.4) was
administered as a negative control. Frogs were monitored for 45
min, made lethargic through hypothermia, and decapitated. Brain
tissue was then dissected for cerebellum RNA extraction and
analysis by PCR-based poly(A)-length assay.
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